Jade Biosciences Inc (JBIO)

Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	35.61%58.92	43.45	34.98	27.40	27.78
Research and Development	38.87%50.07	36.05	28.54	22.01	22.55
Operating Income/Loss	35.61%-58.92	-43.45	-34.98	-27.40	-27.78
Nonoperating Income/Loss	2.36%3.17	3.09	3.11	2.23	-4.36
Income/Loss From Continuing Operations Before Tax	38.16%-55.75	-40.35	-31.87	-25.18	-32.13
Income Tax Expense/Benefit	6.25%0.02	0.02	0.06	-	-
	38.14%-55.77	-40.37	-31.93	-25.18	-32.13
Attributable To Parent	38.14%-55.77	-40.37	-31.93	-25.18	-32.13
Basic Average Shares	5.67%61.05	57.78	7.54	39.58	28.43
Diluted Average Shares	5.67%61.05	57.78	7.54	39.58	28.43
Basic Earnings Per Share	33.33%-0.76	-0.57	-0.11	-0.48	-0.86
Diluted Earnings Per Share	33.33%-0.76	-0.57	-0.11	-0.48	-0.86